Oct 14 |
Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record
|
Oct 14 |
Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal
|
Oct 14 |
Longboard Pharmaceuticals-H. Lundbeck Deal Undervalues Franchise, Truist Says
|
Oct 14 |
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?
|
Oct 14 |
Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck
|
Oct 14 |
Sector Update: Health Care Stocks Advance Premarket Monday
|
Oct 14 |
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal
|
Oct 14 |
Longboard soars as Lundbeck to buy company for equity value of $2.6B
|
Oct 14 |
Denmark's Lundbeck bets on epilepsy drug in $2.6 billion Longboard deal
|
Oct 14 |
Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline
|